PDA

View Full Version : Sunshine completes Adva-27a study in Multidrug Resistant Breast Cancer cell line


News
07-11-2011, 10:24 PM
Sunshine Biopharma Inc., a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line.

More... (http://www.news-medical.net/news/20110712/Sunshine-completes-Adva-27a-study-in-Multidrug-Resistant-Breast-Cancer-cell-line.aspx)